Literature DB >> 25211864

New smallpox vaccines for an ancient scourge.

Sharon E Frey.   

Abstract

The potential use of variola virus, a Class A agent of bioterrorism, remains a concern. In an effort to prepare for a possible smallpox outbreak due to an intentional release of variola, the U.S. government and industry have been evaluating vaccines stored in the National Strategic Stockpile including cell culture grown ACAM2000 and modified vaccinia Ankara, IMVAMUNE, in clinical studies. This paper discusses smallpox vaccines studies conducted at the Saint Louis University Center for Vaccine Development.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25211864      PMCID： PMC6179474     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  22 in total

1.  Clinical responses to undiluted and diluted smallpox vaccine.

Authors:  Sharon E Frey; Robert B Couch; Carol O Tacket; John J Treanor; Mark Wolff; Frances K Newman; Robert L Atmar; Robert Edelman; Carrie M Nolan; Robert B Belshe
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

Review 2.  The looming threat of bioterrorism.

Authors:  D A Henderson
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

3.  Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

Authors:  Paul A Goepfert; Marnie L Elizaga; Alicia Sato; Li Qin; Massimo Cardinali; Christine M Hay; John Hural; Stephen C DeRosa; Olivier D DeFawe; Georgia D Tomaras; David C Montefiori; Yongxian Xu; Lilin Lai; Spyros A Kalams; Lindsey R Baden; Sharon E Frey; William A Blattner; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

4.  VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.

Authors:  Leonard Moise; R Mark Buller; Jill Schriewer; Jinhee Lee; Sharon E Frey; David B Weiner; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2010-11-04       Impact factor: 3.641

5.  Dose-related effects of smallpox vaccine.

Authors:  Sharon E Frey; Frances K Newman; John Cruz; W Brian Shelton; Janice M Tennant; Tamara Polach; Alan L Rothman; Jeffrey S Kennedy; Mark Wolff; Robert B Belshe; Francis A Ennis
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

6.  Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.

Authors:  Koert J Stittelaar; Geert van Amerongen; Ivanela Kondova; Thijs Kuiken; Rob F van Lavieren; Frank H M Pistoor; Hubert G M Niesters; Gerard van Doornum; Ben A M van der Zeijst; Luis Mateo; Paul J Chaplin; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  The immunogenetics of smallpox vaccination.

Authors:  Samuel L Stanley; Sharon E Frey; Patricia Taillon-Miller; Jianhua Guo; Raymond D Miller; Daniel C Koboldt; Michael Elashoff; Ryan Christensen; Nancy L Saccone; Robert B Belshe
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

8.  Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.

Authors:  Stephen R Walsh; Marissa B Wilck; David J Dominguez; Elise Zablowsky; Shringkhala Bajimaya; Lisa S Gagne; Kelly A Verrill; Jane A Kleinjan; Alka Patel; Ying Zhang; Heather Hill; Aruna Acharyya; David C Fisher; Joseph H Antin; Michael S Seaman; Raphael Dolin; Lindsey R Baden
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

9.  Response to smallpox vaccine in persons immunized in the distant past.

Authors:  Sharon E Frey; Frances K Newman; Lihan Yan; Kathleen R Lottenbach; Robert B Belshe
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272

Review 10.  ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.

Authors:  Richard N Greenberg; Jeffrey S Kennedy
Journal:  Expert Opin Investig Drugs       Date:  2008-04       Impact factor: 6.498
View more
  1 in total

1.  Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission.

Authors:  Kristi L Koenig; Christian K Beÿ; Aileen M Marty
Journal:  One Health       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.